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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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The participation of HD families in the search for treatments and a cure
for Huntington’s disease is going global.
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Starting in July 2011, registries of HD patients, at-risk individuals, and
family members from different parts of the world will be combined into a
single database.
Called “Enroll-HD,” this new effort aims to make it easier for scientists to
understand HD, identify potential participants in crucial clinical trials, and
therefore speed the process of finding therapies and a cure.
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The Enroll-HD sponsor, the CHDI Foundation, Inc., released information
on the new program on November 19. Backed by an anonymous donor
who has contributed tens of millions of dollars, CHDI is informally known
as the “cure Huntington’s disease initiative.” CHDI collaborates with
hundreds of scientists from around the world.
Combining databases
Enroll-HD will combine the existing REGISTRY and COHORT databases.
REGISTRY, a Europe-wide study, is run by the Euro-HD Network.
Administered by the Huntington’s Study Group, COHORT stands for
“Cooperative Huntington’s Observational Research Trial.” It operates in
North America and Australia.
Both databases collect information about the genetic status, lifestyle,
medical history, and disease progression of patients and gene-positive
individuals.
Enroll-HD also will include participants from the newly founded Latin
American network of HD-affected families, physicians, and researchers,
the Red Latinoamericana de Huntington. Enroll-HD also will obtain
information from countries such as Singapore, South Africa, and South
Korea.
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“It’s a natural progression to combine the successful HD observational
clinical studies into one worldwide effort that will harness the power of
greater numbers of research participants,” said Dr. G. Bernhard
Landwehrmeyer, a professor at the University of Ulm, Germany, the chair
of Euro-HD, and the principal researcher for Enroll-HD.
People already participating in REGISTRY and COHORT will continue to
consult with the same physicians at regular appointment times.
To learn more about Enroll-HD, please click here.
Latin America’s contribution

curehd.blogspot.com/2010/12/globalizing-fight-against-huntingtons.html

1/4

11/16/21, 1:26 PM

Huntington's Disease Society
of America
International Huntington
Association
Huntington's Disease Drug
Works
Huntington's Disease
Lighthouse
Hereditary Disease
Foundation
Huntington's Disease
Advocacy Center
Thomas Cellini Huntington's
Foundation
HDSA Orange County (CA)
Affiliate
HD Free with PGD!
Stanford HOPES
Earth Source CoQ10, Inc.

HD Blogs and
Individuals
Chris Furbee: Huntingtons
Dance
Angela F.: Surviving
Huntington's?
Heather's Huntington's
Disease Page

At Risk for Huntington's Disease: Globalizing the fight against Huntington's

One of the most striking aspects of Enroll-HD is the inclusion of Latin
America, our neighbors to the south.
Venezuela in particular has played an important part in Huntington’s
research. Dr. Nancy Wexler of the Hereditary Disease Foundation spent
two decades researching the world’s largest extended HD family, located in
the Lake Maracaibo region. Dr. Wexler developed the pedigree (traced the
genetic history) of more than 18,000 individuals and collected more than
4,000 blood samples. This pioneering work helped lead to the discovery of
the HD gene in 1993. (To learn more, see her sister Alice Wexler’s book
Mapping Fate.)
About 580 million people live in Latin America – nearly twice the
population of the United States. In rough terms, this means that some
60,000 people in the region could have Huntington’s. Studying these
individuals and their families will provide a greater understanding of HD’s
devastating effects and its terrible social impact.
It could also benefit HD families victimized by ignorance and poverty.
Although conditions have improved for many in recent decades, most
Latin Americans are still poor by our standards, and many have little or no
access to quality education. In his visits to Colombia, HD activist Phil
Hardt observed HD patients living in deplorable conditions – some even in
old jail cells.
The Red Latinoamericana de Huntington can help raise awareness about
HD throughout the region and perhaps stimulate government support for
care programs and research. It also will tie the HD families and
researchers from Latin America’s countries more tightly together – and
also into the global network of researchers and care and advocacy
programs.
More and faster research
Above all, by including Latin America’s HD families on the rolls of
potential participants in clinical trials, Enroll-HD will vastly expand the
possibilities of testing more drug candidates and carrying out faster
research.
The Huntington’s research community faces an extremely difficult
problem. As an orphan disease, there may not be enough subjects for trials
as potential drugs become ready for testing. This problem is compounded
by the fact that researchers have now identified more than 700 potential
drug targets. Most trials minimally require dozens of participants, and
others utilize hundreds and sometimes thousands of subjects.
In Europe, HD-affected and gene-positive individuals volunteer in
sufficient numbers. Ironically, Americans do not. Despite this country’s
power and overall wealth, denial, fear, and ignorance still dominate many
families affected by HD. This lack of American participation makes EnrollHD even more important.
Guinea pigs?
Some might be concerned that Enroll-HD could become an attempt by
scientists from rich countries to use people from poor nations as guinea
pigs – that is, subjects tested unethically.
Fear of this kind of unequal relationship definitely exists in Latin America.
I have frequently heard such concerns during my own historical research
and travel in the region over the past quarter century.
But it’s unlikely that Enroll-HD will proceed with any kind of negative or
arrogant attitude. All Enroll-HD participants will be protected by the strict
protocols that govern research on human subjects.
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The official Enroll-HD press release reassured current and future
participants that “your samples will continue to be safely stored in the
same biorepositories where they are now kept and all information about
you will be securely stored in accordance with applicable local laws and
regulations regarding the protection of your privacy.”
In addition, CHDI, European researchers, and Latin American
representatives held on-the-ground preparatory meetings in Rio de
Janeiro, Brazil, in February and Buenos Aires, Argentina, in June. The Rio
meeting included representatives from Brazil, Argentina, Chile, Cuba, and
Venezuela. Colombian and Peruvian representatives likely will participate
in the future.
Reactions to the project
“I went to Rio because I wanted to extend a message of Hope to those in
Latin America,” Dr. Ignacio Muñoz-Sanjuan, an HD researcher and the
CHDI representative at the Rio meeting, wrote in his HD science blog.
“This is not an American or European enterprise. It's a global fight to find
a cure, which should be made available to all, rich or poor, in N[ew] Y[ork]
or Maracaibo. But I also went there because we need more people to work
with us. I need every affected person to participate: by donating blood, by
speaking out, by enrolling in observational studies, in clinical studies. We
simply cannot do it without the patients and the people at risk.”
Taíse Cadore, the vice-president of the Associação Brasileira de
Huntington (Brazilian Huntington’s Association), wrote in a report that
her organization “left the meeting with a great sense of optimism. We
recognize the importance of our role in the development of this project and
hope to be counting on the participation of our families.”
“The Red Latinoamericana de Huntington is very excited to become a part
of the global Enroll-HD initiative and collaborate in this way with the
international HD research community to better understand and treat
Huntington’s disease,” Rodrigo Osorio, a native of Chile and the president
of the Latin American organization, said of the official launching of EnrollHD.

Bernhard Landwehrmeyer (right) converses with Rodrigo Osorio at the
CHDI research symposium in Palm Springs, CA, in February (photo by
Gene Veritas).
Inspiring global involvement
As a Latin America scholar and an HD-positive person who lost a mother
to Huntington’s disease in 2006, I felt especially heartened with EnrollHD’s recognition of the global character of disease and the need to include
people of all continents in the search for treatments and in the resultant
benefits.
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I was especially happy to see my friends at the Brazilian Huntington’s
Association receive the attention they deserve as potential contributors to
the fight against HD. Without wealthy benefactors or government support,
they have fought long and hard to build their organization solely on the
grit and donations of HD-affected families.
Their efforts should inspire HD families in America to come out of the
woodwork and redouble our efforts to strengthen our own community,
educate the public about HD, and prepare for participation in clinical
trials. (I will write more on the Brazilian association in my next entry.)
Ultimately, Enroll-HD can help build global awareness about the need to
cure Huntington’s and other neurological disorders. We all share a
common condition and, as we now understand, only together will we
defeat HD and these other maladies.
Posted by Gene Veritas at 2:45 PM
Labels: Associação Brasil Huntington , at-risk , CHDI , clinical trial , cure , EnrollHD , gene , gene-positive , genetic , guinea pig , HD-positive , Huntington's ,
Maracaibo , mother , neurological , treatment , Venezuela

No comments:
Post a Comment

Newer Post

Home

Older Post

Subscribe to: Post Comments (Atom)

curehd.blogspot.com/2010/12/globalizing-fight-against-huntingtons.html

4/4

